Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 2, Issue 10
1 October 2003
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: Synthesis, in vitro cytotoxicity, and pilot in vivo 19F magnetic resonance spectra
William M. Spees; Guangli Yang; Darren Veach; Maria Belen Rubio; Jason A. Koutcher; William Bornmann
View articletitled, A fluorine-labeled methotrexate as a probe for monitoring tumor antifolate pharmacokinetics: Synthesis, <em>in vitro</em> cytotoxicity, and pilot <em>in vivo</em> <sup>19</sup>F magnetic resonance spectra
Open the PDF for in another window
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells
Eric A. Collisson; Celina Kleer; Mei Wu; Abhijit De; Sanjiv S. Gambhir; Sofia D. Merajver; Michael S. Kolodney
View articletitled, Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells
Open the PDF for in another window
Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: Directed apoptotic events in vascular endothelial cells
Yuying Liu; Lawrence H. Cheung; Philip Thorpe; Michael G. Rosenblum
View articletitled, Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)<sub>121</sub> and the serine protease granzyme B: Directed apoptotic events in vascular endothelial cells
Open the PDF for in another window
p16 Gene therapy: A potentially efficacious modality for nasopharyngeal carcinoma
Andrew Wing Cheong Lee; Jian-Hua Li; Willa Shi; Anna Li; Emily Ng; Ta-Jen Liu; Henry J. Klamut; Fei-Fei Liu
View articletitled, <em>p16</em> Gene therapy: A potentially efficacious modality for nasopharyngeal carcinoma
Open the PDF for in another window
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B
Lianne Fuino; Purva Bali; Sylvie Wittmann; Sreenivas Donapaty; Fei Guo; Hirohito Yamaguchi; Hong-Gang Wang; Peter Atadja; Kapil Bhalla
View articletitled, Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B
Open the PDF for in another window
Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro
Natalya M. Khazenzon; Alexander V. Ljubimov; Alexander J. Lakhter; Manabu Fujita; Hironobu Fujiwara; Kiyotoshi Sekiguchi; Lydia M. Sorokin; Noora Petäjäniemi; Ismo Virtanen; Keith L. Black; Julia Y. Ljubimova
View articletitled, Antisense inhibition of laminin-8 expression reduces invasion of human gliomas <em>in vitro</em>
Open the PDF for in another window
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity
Mary L. Disis; Nathalie Scholler; Amber Dahlin; Janice Pullman; Keith L. Knutson; Karl-Erik Hellström; Ingegerd Hellström
View articletitled, Plasmid-based vaccines encoding rat <em>neu</em> and immune stimulatory molecules can elicit rat <em>neu</em>-specific immunity
Open the PDF for in another window
Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy
Yuanhao Li; Yu Chen; Jeanette Dilley; Trini Arroyo; Derek Ko; Peter Working; De-Chao Yu
View articletitled, Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy
Open the PDF for in another window
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer
Tinya J. Abrams; Lesley J. Murray; Enrico Pesenti; Vicky Walker Holway; Tina Colombo; Leslie B. Lee; Julie M. Cherrington; Nancy K. Pryer
View articletitled, Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer
Open the PDF for in another window
Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation
Hong Yang; Zoran Filipovic; David Brown; Samuel N. Breit; Lyubomir T. Vassilev
View articletitled, Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation
Open the PDF for in another window
G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner
Jonathan C. Lai; Luba Benimetskaya; Regina M. Santella; Qiao Wang; Paul S. Miller; Cy A. Stein
View articletitled, G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner
Open the PDF for in another window
Selected isothiocyanates rapidly induce growth inhibition of cancer cells
Yuesheng Zhang; Li Tang; Veronica Gonzalez
View articletitled, Selected isothiocyanates rapidly induce growth inhibition of cancer cells
Open the PDF for in another window
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues
P. James Scrivens; Moulay A. Alaoui-Jamali; Giuseppe Giannini; Taiqi Wang; Martin Loignon; Gerald Batist; Victor A. Sandor
View articletitled, Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues
Open the PDF for in another window
Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts
Lili Liu; Ling Yan; Jon R. Donze; Stanton L. Gerson
View articletitled, Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts
Open the PDF for in another window
Inhibition of lysophosphatidic acid acyltransferase β disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells
Michael Coon; Alexey Ball; Jeannine Pound; Sophe Ap; David Hollenback; Thayer White; John Tulinsky; Lynn Bonham; Deborah K. Morrison; Robert Finney; Jack W. Singer
View articletitled, Inhibition of lysophosphatidic acid acyltransferase β disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells
Open the PDF for in another window

Minireview

New tools for cancer chemotherapy: computational assistance for tailoring treatments
Shea N. Gardner; Michael Fernandes
View articletitled, New tools for cancer chemotherapy: computational assistance for tailoring treatments
Open the PDF for in another window

Advertisement

Breaking
Retifanlimab Kicks Anal Cancer
Durvalumab Findings Will Change Bladder Cancer Care
T-DXd Successfully Controls Brain Metastases
View more recent articles
Latest News
Short-Term Exposure to Air Pollution May Drive Lung Cancer in Never-Smokers
Insufficient Genetic Data Forbode Trial Stoppages
Evidence Points to the Value of Neoadjuvant Therapy for NSCLC
View more recent articles
Research Watch
Post-Fast Refeeding Drives Stem Cell Regeneration via Polyamine Metabolism
The Fanconi Anemia Pathway Mediates Chromothripsis and Resistance to Cancer Therapy
X Chromosome Translocations Drive Sex Bias in a Rare Kidney Cancer Subtype
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept